Search for data related to genes or regions
+
279 Study Datasets reported containing markers in gene or region chr12:13234..4534534 (no 5′ and no 3′ flanks) with -log p ≥ 0 (showing 151-200)
Pages: 1 2 3 4 5 6
No data sets (in No Phenotypes) added to Browser
Phenotype tested in Study Phenotype ontology annotation Total p-values in Study StudyAdd data sets to Browser Related Study data
Lung cancer in ever smokers (HGVPM4232)
  • Lung Neoplasms
110 GWAS of Lung cancer (HGVST2099)
Lymphocyte counts (HGVPM3891)
  • Lymphocyte Count
180 GWAS of Hematological traits (HGVST1903)
Lysine (HGVPM3626)
  • Lysine
2,347 GWAS of Metabolite quantitative traits (HGVST1827)
Macrophage inflammatory protein 1-beta (MIP1b) (HGVPM3697)
  • Chemokine CCL4
6,847 GWAS of Cytokines (HGVST1848)
Macrophage inflammatory protein-1 alpha (MIP1a) (HGVPM3721)
  • Chemokine CCL3
1,120 GWAS of Cytokines (HGVST1848)
Mean corpuscular hemoglobin (HGVPM3876)
  • Erythrocyte Indices
263 GWAS of Hematological traits (HGVST1903)
Mean corpuscular hemoglobin (HGVPM4875)
  • Erythrocyte Indices
96 GWAS of Various traits (HGVST2483)
Mean corpuscular hemoglobin (HGVPM5490)
  • Erythrocyte Indices
35 GWAS of Erythrocytes (HGVST2784)
Mean corpuscular volume (HGVPM3877)
  • Erythrocyte Indices
297 GWAS of Hematological traits (HGVST1903)
Mean corpuscular volume (HGVPM4876)
  • Erythrocyte Indices
111 GWAS of Various traits (HGVST2483)
Mean corpuscular volume (HGVPM5491)
  • Erythrocyte Indices
50 GWAS of Erythrocytes (HGVST2784)
Metabolite levels (betaine) (HGVPM2866)
  • Betaine
2 GWAS of Metabolite levels (HGVST1564)
Methanol (HGVPM3630)
  • Methanol
3,080 GWAS of Metabolite quantitative traits (HGVST1827)
Migraine (HGVPM3353)
  • Migraine Disorders
59 GWAS of Migraine (HGVST1720)
Migraine (HGVPM4643)
  • Migraine Disorders
44 GWAS of Migraine (HGVST2348)
Migraine - clinic-based (HGVPM3352)
  • Migraine Disorders
37 GWAS of Migraine (HGVST1720)
Migraine without aura (HGVPM3354)
  • Migraine without Aura
32 GWAS of Migraine (HGVST1720)
Migraine without aura (HGVPM4644)
  • Migraine without Aura
7 GWAS of Migraine (HGVST2348)
Monoclonal gammopathy of undetermined significance (HGVPM3729)
  • Monoclonal Gammopathy of Undetermined Significance
4,999 GWAS of Monoclonal gammopathy of unknown significance (MGUS) (HGVST1853)
Monocyte chemotactic protein-1 (MCP1) (HGVPM3696)
  • Chemokine CCL2
2,953 GWAS of Cytokines (HGVST1848)
Monocyte count (HGVPM3893)
  • Monocytes
236 GWAS of Hematological traits (HGVST1903)
Monocyte percentage of white cells (HGVPM3880)
  • Monocytes
224 GWAS of Hematological traits (HGVST1903)
Monokine induced by interferon-gamma (MIG) (HGVPM3720)
  • Chemokine CXCL9
1,361 GWAS of Cytokines (HGVST1848)
Myoinositol (HGVPM3633)
  • Inositol
2,367 GWAS of Metabolite quantitative traits (HGVST1827)
Narcolepsy (HGVPM165)
  • Narcolepsy
244,737 GWAS of narcolepsy in a Japanese population (HGVST115)
Narcolepsy with cataplexy (Age cataplexy onset) (HGVPM2942)
  • Cataplexy
  • Narcolepsy
1 GWAS of Narcolepsy with cataplexy (HGVST1594)
Nasal root breadth (HGVPM3661)
  • Facial Bones
11,613 GWAS of Facial features (HGVST1841)
Nephropathy (HGVPM994)
  • Glomerulonephritis, IGA
286,197 GWAS of nephropathy (HGVST558)
Neuropathic pain-like symptoms (HGVPM3681)
  • Neuralgia
5,492 GWAS of Neuropathic pain-like symptoms (HGVST1846)
Neutrophil percentage of granulocytes (HGVPM3869)
  • Neutrophils
168 GWAS of Hematological traits (HGVST1903)
Nose bridge breadth (HGVPM3664)
  • Nasal Bone
11,813 GWAS of Facial features (HGVST1841)
Nose profile (HGVPM3666)
  • Nose
10,155 GWAS of Facial features (HGVST1841)
Nose protrusion (HGVPM3667)
  • Nose
12,559 GWAS of Facial features (HGVST1841)
Nose tip shape (HGVPM3668)
  • Nose
9,300 GWAS of Facial features (HGVST1841)
Nose wing breadth (HGVPM3665)
  • Nasal Bone
11,817 GWAS of Facial features (HGVST1841)
Obesity (early onset extreme) (HGVPM3098)
  • Obesity
18 GWAS of Obesity (early onset extreme) (HGVST1631)
Ornithine (HGVPM3627)
  • Ornithine
2,477 GWAS of Metabolite quantitative traits (HGVST1827)
Oxaloacetate (HGVPM3619)
  • Oxaloacetic Acid
2,588 GWAS of Metabolite quantitative traits (HGVST1827)
Paclitaxel disposition in epithelial ovarian cancer (HGVPM6326)
  • Paclitaxel
31 GWAS of Carboplatin and paclitaxel disposition (HGVST3241)
Parkinson's disease (HGVPM3)
  • Parkinson Disease
792,112 GWAS of Parkinson's disease (HGVST6)
Parkinson's disease (HGVPM126)
  • Parkinson Disease
192,227 GWAS of Parkinson's disease (HGVST83)
Parkinson's disease (HGVPM575)
  • Parkinson Disease
2,987 GWAS of Parkinson's disease (HGVST83)
Partial epilepsies (HGVPM929)
  • Epilepsies, Partial
528,036 GWAS of partial epilepsies (HGVST522)
Pattern recognition memory (HGVPM849)
  • Neuropsychological Tests
100 GWAS of cognitive performance (HGVST481)
Platelet count (HGVPM3885)
  • Platelet Count
273 GWAS of Hematological traits (HGVST1903)
Platelet count (HGVPM4892)
  • Platelet Count
96 GWAS of Various traits (HGVST2483)
Platelet derived growth factor BB (PDGFbb) (HGVPM3698)
  • Platelet-Derived Growth Factor
1,815 GWAS of Cytokines (HGVST1848)
Platelet distribution width (HGVPM3886)
  • Blood Platelets
200 GWAS of Hematological traits (HGVST1903)
Plateletcrit (HGVPM3892)
  • Platelet Count
258 GWAS of Hematological traits (HGVST1903)
Principal component axis 1, CANTAB measures (HGVPM852)
  • Behavioral Sciences
100 GWAS of cognitive performance (HGVST481)